Amgen Inc. (AMGN)
Drug Manufacturers - General · Healthcare · $182.2B
Intrinsic Value (Consensus)
$397.06
Current Price
$337.64
Margin of Safety
+17.6%
17.6% Below Intrinsic Value
Value: $397
Price: $338
Valuation Model Estimates
Current Price: $337.64
DCF (Discounted Cash Flow)
$351.27
Graham Number
$72.05
Earnings Power Value
$197.04
Relative Value (P/E)
$287.68
Dividend Discount Model
$752.24
Consensus Value
$397.06
Model Assumptions
Discount Rate
10.3%
Growth Rate
7.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
70
Profitability
25/25
Strength
13/25
Valuation
19/25
Growth
13/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 631% (above 200% is risky)
Strong profitability — ROE of 89% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $14.38
- EPS (Forward)
- $15.39
- Book Value
- $16.04
- P/E Ratio
- 25.0
- Forward P/E
- 20.8
- PEG Ratio
- —
- ROE
- 89.1%
- Debt/Equity
- 631%
- Revenue Growth
- 10.0%
- Earnings Growth
- 7.0%
- Dividend Yield
- 0.7%
- Beta
- 0.40
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance